Details of the Drug | DrugMAP

General Information of Drug (ID: DMBWAV7)

Drug Name	PMID28766366-Compound-Scheme24-11H-pyrido[4,3-a]carbazole
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			243.26
	Logarithm of the Partition Coefficient (xlogp)			3.3
	Rotatable Bond Count (rotbonds)			0
	Hydrogen Bond Donor Count (hbonddonor)			1
	Hydrogen Bond Acceptor Count (hbondacc)			2
Chemical Identifiers	Formula C16H9N3 IUPAC Name 11H-pyrido[4,3-a]carbazole-6-carbonitrile Canonical SMILES C1=CC=C2C(=C1)C3=C(C=C4C=NC=CC4=C3N2)C#N InChI InChI=1S/C16H9N3/c17-8-10-7-11-9-18-6-5-12(11)16-15(10)13-3-1-2-4-14(13)19-16/h1-7,9,19H InChIKey DCPBIOSSTDLFHO-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 12248893 TTD ID D0GV3X

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)	TTSBVFO	DYR1A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199.